According to Zhitong Finance App News, Jingfang Pharmaceutical-B (02595.HK) announced that on July 14, 2026 (after the trading period), the company entered into a placement agreement with the placement agent. According to this, the placement agent has agreed to act as the Company's agent and do its best to induce a total of no less than six undertakers to purchase 13.6 million new H shares at an placement price of HK$34.69 per H share in accordance with the terms and conditions set forth in the placement agreement.

According to Zhitong Finance App News, Jingfang Pharmaceutical-B (02595.HK) announced that on July 14, 2026 (after the trading period), the company entered into a placement agreement with the placement agent. According to this, the placement agent has agreed to act as the Company's agent and do its best to induce a total of no less than six undertakers to purchase 13.6 million new H shares at an placement price of HK$34.69 per H share in accordance with the terms and conditions set forth in the placement agreement.